TrialJournal of the peripheral nervous system : JPNS2018

Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial.

Satoshi Kuwabara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.